The COVID-19 Pandemic's impact on sustainability and expansion of a Pediatric Early Warning System in resource-limited hospitals.

COVID-19 Latin America PEWS implementation science pediatric early warning system pediatric oncology quality improvement collaborative resource-limited

Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
05 2023
Historique:
revised: 11 03 2023
received: 22 07 2022
accepted: 16 03 2023
medline: 7 6 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

The COVID-19 pandemic impacted healthcare delivery worldwide, including pediatric cancer care, with a disproportionate effect in resource-limited settings. This study evaluates its impact on existing quality improvement (QI) programs. We conducted 71 semi-structured interviews of key stakeholders at five resource-limited pediatric oncology centers participating in a collaborative to implement Pediatric Early Warning System (PEWS). Interviews were conducted virtually using a structured interview guide, recorded, transcribed, and translated into English. Two coders developed a codebook of a priori and inductive codes and independently coded all transcripts, achieving a kappa of 0.8-0.9. Thematic analysis explored the impact of the pandemic on PEWS. All hospitals reported limitations in material resources, reduction in staffing, and impacts on patient care due to the pandemic. However, the impact on PEWS varied across centers. Identified factors that promoted or limited ongoing PEWS use included the availability of material resources needed for PEWS, staff turnover, PEWS training for staff, and the willingness of staff and hospital leaders to prioritize PEWS. Consequently, some hospitals were able to sustain PEWS; others halted or reduced PEWS use to prioritize other work. Similarly, the pandemic delayed plans at all hospitals to expand PEWS to other units. Several participants were hopeful for future expansion of PEWS post-pandemic. The COVID-19 pandemic created challenges for sustainability and scale of PEWS, an ongoing QI program, in these resource-limited pediatric oncology centers. Several factors mitigated these challenges and promoted ongoing PEWS use. These results can guide strategies to sustain effective QI interventions during future health crises.

Sections du résumé

BACKGROUND
The COVID-19 pandemic impacted healthcare delivery worldwide, including pediatric cancer care, with a disproportionate effect in resource-limited settings. This study evaluates its impact on existing quality improvement (QI) programs.
METHODS
We conducted 71 semi-structured interviews of key stakeholders at five resource-limited pediatric oncology centers participating in a collaborative to implement Pediatric Early Warning System (PEWS). Interviews were conducted virtually using a structured interview guide, recorded, transcribed, and translated into English. Two coders developed a codebook of a priori and inductive codes and independently coded all transcripts, achieving a kappa of 0.8-0.9. Thematic analysis explored the impact of the pandemic on PEWS.
RESULTS
All hospitals reported limitations in material resources, reduction in staffing, and impacts on patient care due to the pandemic. However, the impact on PEWS varied across centers. Identified factors that promoted or limited ongoing PEWS use included the availability of material resources needed for PEWS, staff turnover, PEWS training for staff, and the willingness of staff and hospital leaders to prioritize PEWS. Consequently, some hospitals were able to sustain PEWS; others halted or reduced PEWS use to prioritize other work. Similarly, the pandemic delayed plans at all hospitals to expand PEWS to other units. Several participants were hopeful for future expansion of PEWS post-pandemic.
CONCLUSION
The COVID-19 pandemic created challenges for sustainability and scale of PEWS, an ongoing QI program, in these resource-limited pediatric oncology centers. Several factors mitigated these challenges and promoted ongoing PEWS use. These results can guide strategies to sustain effective QI interventions during future health crises.

Identifiants

pubmed: 37022012
doi: 10.1002/cam4.5876
pmc: PMC10242859
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11878-11888

Informations de copyright

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Trop Med Int Health. 2013 Jul;18(7):879-86
pubmed: 23600592
BMJ Glob Health. 2021 May;6(5):
pubmed: 34039587
Cancer. 2017 Dec 15;123(24):4903-4913
pubmed: 28881451
Cancer. 2017 Aug 1;123(15):2965-2974
pubmed: 28440868
Front Oncol. 2021 Jun 23;11:660051
pubmed: 34249696
Cancer Med. 2023 May;12(10):11878-11888
pubmed: 37022012
Resuscitation. 2016 Dec;109:87-109
pubmed: 27496259
Annu Rev Public Health. 2018 Apr 1;39:55-76
pubmed: 29328872
Glob Health Sci Pract. 2020 Dec 23;8(4):838-845
pubmed: 33361246
Lancet Oncol. 2021 Oct;22(10):1416-1426
pubmed: 34454651
JCO Glob Oncol. 2021 Sep;7:1529-1536
pubmed: 34748391
J Patient Cent Res Rev. 2021 Oct 18;8(4):347-353
pubmed: 34722804
Arch Dis Child. 2017 Jun;102(6):487-495
pubmed: 28292743
J Subst Abuse Treat. 2021 Oct;129:108388
pubmed: 34080556
JAMA Netw Open. 2022 Mar 1;5(3):e221547
pubmed: 35262714
Lancet Child Adolesc Health. 2021 May;5(5):332-340
pubmed: 33675698
Cancer. 2019 Nov 15;125(22):4052-4058
pubmed: 31436324
Curr Opin Pediatr. 2013 Feb;25(1):3-15
pubmed: 23295716
Front Pediatr. 2022 May 03;10:885633
pubmed: 35592840
Cancer. 2022 Apr 1;128(7):1493-1502
pubmed: 35067925
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Pediatr Crit Care Med. 2017 Jul;18(7):655-660
pubmed: 28445240
Int J Qual Health Care. 2017 Dec 01;29(8):973-980
pubmed: 29177409
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Pediatr Nurs. 2017 Jan - Feb;32:52-58
pubmed: 27823915
J Pediatr Nurs. 2019 May - Jun;46:39-47
pubmed: 30836203
Front Health Serv. 2022 May 20;2:897227
pubmed: 36925818
Pediatr Blood Cancer. 2022 Oct;69(10):e29748
pubmed: 35593012
Glob Qual Nurs Res. 2022 Feb 26;9:23333936221080969
pubmed: 35237707
Front Pediatr. 2019 Jan 08;6:410
pubmed: 30671424
JCO Glob Oncol. 2020 Jul;6:1079-1086
pubmed: 32673079

Auteurs

Parima P Wiphatphumiprates (PP)

Rhodes College, Memphis, Tennessee, USA.

Dylan E Graetz (DE)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Gia Ferrara (G)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Maria Puerto-Torres (M)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Srinithya R Gillipelli (SR)

Baylor College of Medicine, Houston, Texas, USA.

Paul Elish (P)

Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Hilmarie Muniz-Talavera (H)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Alejandra Gonzalez-Ruiz (A)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Miriam Armenta (M)

Pediatric Oncology, Hospital General de Tijuana, Tijuana, Mexico.

Camila Barra (C)

Pediatric Oncology, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.

Zulma Carpio (Z)

Pediatric Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Cinthia Hernandez (C)

Pediatric Oncology, Hospital Infantil Teletón de Oncología, Querétaro, Mexico.

Susana Juarez (S)

Pediatrics, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico.

Jose de Jesus Loeza (J)

Pediatric Oncology, Centro Estatal de Cancerología, Xalapa, Mexico.

Alejandra Mendez (A)

Pediatric Critical Care, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.

Erika Montalvo (E)

Pediatric Critical Care, Hospital Oncológico Solca Núcleo de Quito, Quito, Ecuador.

Eulalia Penafiel (E)

Pediatric Oncology, Instituto del Cáncer SOLCA Cuenca, Cuenca, Ecuador.

Estuardo Pineda (E)

Pediatric Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador.

Virginia McKay (V)

Bloom School of Medicine, Washington University, St. Louis, Missouri, USA.

Asya Agulnik (A)

Global Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH